CHRNA7

CHRNA7

Target · Nicotinic receptor subunit

CHRNA7 Cholinergic receptor nicotinic alpha 7 subunit · neuronal acetylcholine receptor subunit alpha-7

CHRNA7 (cholinergic receptor nicotinic alpha 7 subunit, a7nAChR) is a subunit of neuronal nicotinic acetylcholine receptors, which are pentameric ligand-gated cation channels. It forms homopentameric channels with high calcium permeability and also acts in non-neuronal inflammatory signalling. Browse Assay Genie's current range of CHRNA7 research reagents below, or read on for the biology behind the target.

Postsynaptic cell membraneLigand-gated calcium channelCholinergic anti-inflammatory pathway
502 aa
Protein length
~56 kDa
Molecular weight
15q13.3
Gene locus
Ion channel
Protein family
Target information

What is CHRNA7 (cholinergic receptor nicotinic alpha 7 subunit)?

CHRNA7 is a component of neuronal acetylcholine receptors (nAChRs), excitatory neurotransmitter receptors that mediate synaptic transmission in the nervous system and at the neuromuscular junction. Once acetylcholine, nicotine or another agonist binds, the receptor undergoes a marked conformational change affecting all subunits and opens an ion-conducting channel across the plasma membrane. The CHRNA7 protein forms homopentameric receptors that are abundant in the central nervous system and are characterised by fast desensitisation and high calcium permeability. It also forms heteropentamers with CHRNB2, mainly in basal forebrain cholinergic neurons. These receptors are a major component of brain nicotinic receptors that are blocked by alpha-bungarotoxin.

Functionally, CHRNA7 modulates calcium-dependent signalling pathways and influences the release of neurotransmitters including dopamine, glutamate and GABA. It is not restricted to neurons: it is also expressed in lymphocytes, monocytes and macrophages, and in the urothelium, where it modulates reflex bladder activity. In T cells, activation induces metabotropic signalling that raises intracellular Ca2+ independently of ionotropic function. In macrophages, it is required for acetylcholine-mediated inhibition of TNF and other inflammatory cytokine release, selectively suppressing pro-inflammatory cytokines while leaving anti-inflammatory cytokines undisturbed. This cholinergic anti-inflammatory pathway acts by inhibiting NFKB nuclear translocation and activating JAK2-STAT3 signalling, independently of channel activity.

The CHRNA7 gene belongs to the ligand-gated ion channel family, acetylcholine receptor subfamily, within the HGNC group of cholinergic receptors, nicotinic subunits. Each subunit has a conserved N-terminal extracellular domain, transmembrane domains and a variable cytoplasmic loop. The gene lies in a region identified as a susceptibility locus for juvenile myoclonic epilepsy and a location implicated in the genetic transmission of schizophrenia. A recent partial duplication in this region produced a hybrid with the novel FAM7A gene, and alternative splicing yields multiple transcript variants. Mouse and rat orthologues are both named Chrna7.

Neuroscience and synaptic transmission

CHRNA7 forms calcium-permeable homopentameric channels in the central nervous system and modulates dopamine, glutamate and GABA release.

Neuroinflammation and immunology

In macrophages, CHRNA7 mediates acetylcholine-dependent inhibition of TNF and other pro-inflammatory cytokines through the cholinergic anti-inflammatory pathway.

Calcium signalling studies

The receptor modulates calcium-dependent pathways, including metabotropic Ca2+ increases in T cells that are independent of ionotropic receptor function.

Neurological disease genetics

The CHRNA7 locus is a susceptibility region for juvenile myoclonic epilepsy and is implicated in the genetic transmission of schizophrenia.

Background

CHRNA7 frequently asked questions

What does CHRNA7 do?

CHRNA7 is a subunit of neuronal nicotinic acetylcholine receptors. It forms homopentameric, calcium-permeable, ligand-gated cation channels that mediate fast synaptic signalling and influence neurotransmitter release. It also drives anti-inflammatory signalling in macrophages by inhibiting NFKB nuclear translocation and activating JAK2-STAT3.

What other names does CHRNA7 go by?

The HGNC name is cholinergic receptor nicotinic alpha 7 subunit, and UniProt calls the protein neuronal acetylcholine receptor subunit alpha-7. The alias a7nAChR is widely used. Earlier names include cholinergic receptor, nicotinic, alpha polypeptide 7. Alternative splicing produces multiple transcript variants.

Is CHRNA7 conserved and linked to disease?

Orthologues exist in mouse and rat, both named Chrna7, so rodent models are commonly used; check the datasheet of any product for its validated reactivity. The human gene lies in a susceptibility locus for juvenile myoclonic epilepsy and a region implicated in schizophrenia genetics.

Explore

Related targets

Other nicotinic acetylcholine receptor alpha subunits with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P36544; product specifications from Assay Genie datasheets.

CHRNA7 Product listing